Question 1

How might supplementary oxygen improve my breathing during exercise?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT clinical trial (NCT00249093). Contact the study team or your healthcare provider for specific answers.

Question 2

What tests will I need to perform to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT clinical trial (NCT00249093). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects associated with using supplementary oxygen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT clinical trial (NCT00249093). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this trial compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT clinical trial (NCT00249093). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the expected duration of my participation in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT clinical trial (NCT00249093). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I need to travel to a specific location for the trial, and how often?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT clinical trial (NCT00249093). Contact the study team or your healthcare provider for specific answers.

What this study is about